GoHealth's Earnings Announcement Overview
GoHealth (NASDAQ: GOCO) is set to release its quarterly earnings report soon. Investors are likely keenly awaiting updates, as they provide crucial information on the company's financial health and future prospects.
Expected Earnings Per Share
Analysts currently predict that GoHealth will report an earnings per share (EPS) of $-2.02 for this quarter, a figure that highlights the challenges the company faces.
Past Earnings Performance Analysis
In the previous quarter, GoHealth fell short of EPS expectations by $2.50, which triggered a significant 2.44% decline in the stock price the following day. The anticipated figures provide a juxtaposition against GoHealth’s past performance.
Overview of Previous Earnings Reports
To better understand its trajectory, let’s revisit GoHealth’s recent earnings record:
Quarterly EPS Estimates vs. Actuals:
- **Q2 2025**: Estimate $-2.60, Actual $-5.10 (Price Change: -2.0%)
- **Q1 2025**: Estimate $-0.26, Actual $-0.52 (Price Change: -8.0%)
- **Q4 2024**: Estimate $1.16, Actual $1.56 (Price Change: -8.0%)
- **Q3 2024**: Estimate $-3.19, Actual $-4.85 (Price Change: +1.0%)
Market Performance of GoHealth's Stock
As of the latest update, GoHealth shares were trading at approximately $3.42, marking a staggering decline of over 72.54% over the past year. This dip raises concerns for long-term shareholders who are understandably apprehensive leading up to the earnings release.
Insights from Analysts
For anyone involved in GoHealth or considering an investment, it's vital to stay tuned to market sentiments and expectations. The general consensus among analysts currently rates GoHealth as Neutral, based on one analyst rating. The average price target over the next year stands at $12.0, suggesting a potential upside of nearly 250.88% if targets are met.
Comparative Analysis with Industry Peers
Understanding how GoHealth stacks up against its competitors is crucial for assessing market positions. When looking at key industry players, GoHealth's performance metrics and analyst ratings reveal significant insights into relative market dynamics.
Snapshot of Peer Analysis
This section will encapsulate essential metrics for GoHealth in comparison with its peers:
- **Consensus Rating**: Neutral
- **Revenue Growth**: -11.17%
- **Gross Profit**: $61.64M
- **Return on Equity**: -25.50%
Understanding GoHealth's Market Position
GoHealth Inc is a digital health marketplace that primarily focuses on health insurance, specifically Medicare plans, including Medicare Advantage, Supplement, and prescription drug plans. The company's technology aims to simplify the healthcare decision-making process for consumers.
Financial Performance Breakdown
Let’s delve deeper into GoHealth's financial landscape:
Market Capitalization: GoHealth's market cap suggests a smaller scale than many of its competitors, influenced by variable factors affecting growth expectations and business operations.
Revenue Decline: In the last quarter, the company registered a revenue decline of -11.17%, indicating tough market conditions forcing adjustments to business strategies.
Net Margin: Currently, GoHealth's net margin shows a trend below industry averages, revealing probable difficulties in managing costs effectively.
Return on Equity (ROE): The company's ROE remains significantly lower than expected, which may raise concerns for current and prospective shareholders about their returns.
Asset Utilization: GoHealth's return on assets (ROA) also lags behind industry competitors, indicating possible inefficiencies in asset management.
Debt Management: GoHealth's debt-to-equity ratio exceeds industry averages at 3.11, suggesting heightened levels of debt that could impact financial stability.
Frequently Asked Questions
What is GoHealth's anticipated earnings per share?
GoHealth is expected to report an EPS of $-2.02.
How has GoHealth performed in past quarters?
GoHealth missed EPS expectations last quarter by $2.50, leading to a stock price drop.
How does GoHealth's stock perform compared to its peers?
GoHealth has experienced a dramatic decline of 72.54% over the past year, making it underperform compared to industry standards.
What are analyst expectations for GoHealth's stock price?
The average price target stands at $12.0, suggesting a potential upside of 250.88%.
What is GoHealth's approach in the market?
GoHealth aims to assist consumers in health plan selection through technology focused on Medicare solutions.
